An experimental antibiotic, zosurabalpin, to fight a deadly superbug has entered the final human trials. Currently, no new ...

Swiss drugmaker Roche (ROG.S), said on Monday it would advance testing of an antibiotic against a common drug-resistant ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

Since the discovery of penicillin nearly a century ago, antimicrobial resistance (AMR) has become a stealthy, pervasive enemy ...

GSK and Spero Therapeutics’ Phase III trial of their oral antibiotic for complicated urinary tract infections (cUTI) will end ...

Swiss drugmaker Roche is advancing a new antibiotic into its final human testing phase, potentially saving millions from ...

A new antibiotic that could treat a common ‘superbug’ is to be tested on patients. The drug Zosurabalpin, is being developed ...

Australia’s second-largest private hospital operator, Healthscope, is in receivership with ten non-binding offers for ...

Hundreds of patients will be recruited for a major trial of what could be the first new antibiotic of its kind for 50 years.

Acinetobacter baumannii and the closely related genomic species 3 and 13TU are clinically the most important species. A. baumannii is a major cause of hospital-acquired infections in patients who ...